502 related articles for article (PubMed ID: 21752277)
1. SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques.
Hu H; Gama L; Aye PP; Clements JE; Barry PA; Lackner AA; Weissman D
Retrovirology; 2011 Jul; 8():57. PubMed ID: 21752277
[TBL] [Abstract][Full Text] [Related]
2. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
3. Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques.
Malzahn J; Shen C; Caruso L; Ghosh P; Sankapal SR; Barratt-Boyes S; Gupta P; Chen Y
Virol J; 2012 Nov; 9():269. PubMed ID: 23150992
[TBL] [Abstract][Full Text] [Related]
4. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
5. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
[TBL] [Abstract][Full Text] [Related]
6. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.
Hansen SG; Ford JC; Lewis MS; Ventura AB; Hughes CM; Coyne-Johnson L; Whizin N; Oswald K; Shoemaker R; Swanson T; Legasse AW; Chiuchiolo MJ; Parks CL; Axthelm MK; Nelson JA; Jarvis MA; Piatak M; Lifson JD; Picker LJ
Nature; 2011 May; 473(7348):523-7. PubMed ID: 21562493
[TBL] [Abstract][Full Text] [Related]
7. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
[TBL] [Abstract][Full Text] [Related]
8. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
Helmold Hait S; Vargas-Inchaustegui DA; Musich T; Mohanram V; Tuero I; Venzon DJ; Bear J; Rosati M; Vaccari M; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463978
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation.
Bricker KM; Obregon-Perko V; Uddin F; Williams B; Uffman EA; Garrido C; Fouda GG; Geleziunas R; Robb M; Michael N; Barouch DH; Chahroudi A
PLoS Pathog; 2020 Oct; 16(10):e1008954. PubMed ID: 33104758
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4
McGary CS; Deleage C; Harper J; Micci L; Ribeiro SP; Paganini S; Kuri-Cervantes L; Benne C; Ryan ES; Balderas R; Jean S; Easley K; Marconi V; Silvestri G; Estes JD; Sekaly RP; Paiardini M
Immunity; 2017 Oct; 47(4):776-788.e5. PubMed ID: 29045906
[TBL] [Abstract][Full Text] [Related]
11. Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac.
Cervasi B; Carnathan DG; Sheehan KM; Micci L; Paiardini M; Kurupati R; Tuyishime S; Zhou XY; Else JG; Ratcliffe SJ; Ertl HC; Silvestri G
J Virol; 2013 Sep; 87(17):9420-30. PubMed ID: 23804645
[TBL] [Abstract][Full Text] [Related]
12. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
13. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.
Mueller YM; Do DH; Altork SR; Artlett CM; Gracely EJ; Katsetos CD; Legido A; Villinger F; Altman JD; Brown CR; Lewis MG; Katsikis PD
J Immunol; 2008 Jan; 180(1):350-60. PubMed ID: 18097036
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
Virnik K; Rosati M; Medvedev A; Scanlan A; Walsh G; Dayton F; Broderick KE; Lewis M; Bryson Y; Lifson JD; Ruprecht RM; Felber BK; Berkower I
PLoS One; 2020; 15(3):e0228163. PubMed ID: 32130229
[TBL] [Abstract][Full Text] [Related]
15. Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: a proof of concept study in macaques.
Koopman G; Beenhakker N; Hofman S; Walther-Jallow L; Mäkitalo B; Mooij P; Anderson J; Verschoor E; Bogers WM; Heeney JL; Spetz AL
Vaccine; 2012 Mar; 30(15):2523-34. PubMed ID: 22314133
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
17. Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.
Kenway-Lynch CS; Das A; Lackner AA; Pahar B
J Virol; 2014 Aug; 88(16):9442-57. PubMed ID: 24920807
[TBL] [Abstract][Full Text] [Related]
18. A Novel Immunogen Selectively Eliciting CD8
Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
[TBL] [Abstract][Full Text] [Related]
19. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
[TBL] [Abstract][Full Text] [Related]
20. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques.
Cadena AM; Ventura JD; Abbink P; Borducchi EN; Tuyishime H; Mercado NB; Walker-Sperling V; Siamatu M; Liu PT; Chandrashekar A; Nkolola JP; McMahan K; Kordana N; Hamza V; Bondzie EA; Fray E; Kumar M; Fischinger S; Shin SA; Lewis MG; Siliciano RF; Alter G; Barouch DH
Nat Commun; 2021 Mar; 12(1):1474. PubMed ID: 33674572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
